Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

1.

Urine specimen detection of concurrent nonprescribed medicinal and illicit drug use in patients prescribed buprenorphine.

Guo AY, Ma JD, Best BM, Atayee RS.

J Anal Toxicol. 2013 Nov-Dec;37(9):636-41. doi: 10.1093/jat/bkt082. Epub 2013 Sep 29.

PMID:
24080973
[PubMed - indexed for MEDLINE]
2.

Oral fluid drug testing of chronic pain patients. I. Positive prevalence rates of licit and illicit drugs.

Heltsley R, DePriest A, Black DL, Robert T, Marshall L, Meadors VM, Caplan YH, Cone EJ.

J Anal Toxicol. 2011 Oct;35(8):529-40.

PMID:
22004671
[PubMed - indexed for MEDLINE]
Free Article
3.

A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.

Melanson SE, Snyder ML, Jarolim P, Flood JG.

J Anal Toxicol. 2012 Apr;36(3):201-6. doi: 10.1093/jat/bks003.

PMID:
22417836
[PubMed - indexed for MEDLINE]
4.

Illicit drug use correlates with negative urine drug test results for prescribed hydrocodone, oxycodone, and morphine.

Pesce A, West C, Gonzales E, Rosenthal M, West R, Mikel C, Almazan P, Latyshev S, Horn P.

Pain Physician. 2012 Sep-Oct;15(5):E687-92. Review.

PMID:
22996862
[PubMed - indexed for MEDLINE]
Free Article
5.

Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).

Manchikanti L, Malla Y, Wargo BW, Cash KA, Pampati V, Damron KS, McManus CD, Brandon DE.

Pain Physician. 2010 Jan-Feb;13(1):E1-E22.

PMID:
20119473
[PubMed - indexed for MEDLINE]
Free Article
6.

Differentiating medicinal from illicit use in positive methamphetamine results in a pain population.

West R, Pesce A, West C, Mikel C, Velasco J, Gonzales E, Dizon Z, Almazan P, Latyshev S.

J Anal Toxicol. 2013 Mar;37(2):83-9. doi: 10.1093/jat/bks096. Epub 2013 Jan 11.

PMID:
23316029
[PubMed - indexed for MEDLINE]
7.
8.
9.

Illicit drug use in the pain patient population decreases with continued drug testing.

Pesce A, West C, Rosenthal M, Mikel C, West R, Crews B, Almazan P, Latyshev S, Horn PS.

Pain Physician. 2011 Mar-Apr;14(2):189-93.

PMID:
21412373
[PubMed - indexed for MEDLINE]
Free Article
10.

An evaluation of the diagnostic accuracy of liquid chromatography-tandem mass spectrometry versus immunoassay drug testing in pain patients.

Pesce A, Rosenthal M, West R, West C, Crews B, Mikel C, Almazan P, Latyshev S.

Pain Physician. 2010 May-Jun;13(3):273-81.

PMID:
20495592
[PubMed - indexed for MEDLINE]
Free Article
11.

Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid.

Cone EJ, Clarke J, Tsanaclis L.

J Anal Toxicol. 2007 Oct;31(8):424-33. Erratum in: J Anal Toxicol. 2008 Mar;32(2):199-200.

PMID:
17988455
[PubMed - indexed for MEDLINE]
Free Article
12.

Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing.

Huestis MA, Cone EJ, Wong CJ, Umbricht A, Preston KL.

J Anal Toxicol. 2000 Oct;24(7):509-21.

PMID:
11043653
[PubMed - indexed for MEDLINE]
Free Article
13.

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse.

Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR.

Arch Gen Psychiatry. 1997 Aug;54(8):713-20.

PMID:
9283506
[PubMed - indexed for MEDLINE]
14.

Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index.

Strain EC, Stitzer ML, Liebson IA, Bigelow GE.

J Clin Psychopharmacol. 1996 Feb;16(1):58-67.

PMID:
8834420
[PubMed - indexed for MEDLINE]
15.

Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.

Schottenfeld RS, Chawarski MC, Pakes JR, Pantalon MV, Carroll KM, Kosten TR.

Am J Psychiatry. 2005 Feb;162(2):340-9.

PMID:
15677600
[PubMed - indexed for MEDLINE]
16.

Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.

McCance-Katz EF, Sullivan LE, Nallani S.

Am J Addict. 2010 Jan-Feb;19(1):4-16. doi: 10.1111/j.1521-0391.2009.00005.x. Review.

PMID:
20132117
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?

Manchikanti L, Manchukonda R, Pampati V, Damron KS, Brandon DE, Cash KA, McManus CD.

Pain Physician. 2006 Apr;9(2):123-9.

PMID:
16703972
[PubMed - indexed for MEDLINE]
Free Article
18.

Marijuana correlates with use of other illicit drugs in a pain patient population.

Pesce A, West C, Rosenthal M, West R, Crews B, Mikel C, Almazan P, Latyshev S, Horn PS.

Pain Physician. 2010 May-Jun;13(3):283-7.

PMID:
20495593
[PubMed - indexed for MEDLINE]
Free Article
19.

[Buprenorphine vs. methadone as maintenance treatment for opioid dependence].

Fischer G, Gombas W, Eder H, Jagsch R, Stühlinger G, Aschauer HN, Kasper S.

Nervenarzt. 1999 Sep;70(9):795-802. German.

PMID:
10522247
[PubMed - indexed for MEDLINE]
20.

Sweat testing in opioid users with a sweat patch.

Kintz P, Tracqui A, Mangin P, Edel Y.

J Anal Toxicol. 1996 Oct;20(6):393-7.

PMID:
8889674
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk